Raymond James Maintains Strong Buy on Medical Properties Trust, Lowers Price Target to $20
Raymond James analyst Jonathan Hughes maintains Medical Properties Trust (NYSE:MPW) with a Strong Buy and lowers the price target from $24 to $20.
Credit Suisse Downgrades Medical Properties Trust to Neutral, Lowers Price Target to $17
Credit Suisse analyst Omotayo Okusanya downgrades Medical Properties Trust (NYSE:MPW) from Outperform to Neutral and lowers the price target from $23 to $17.
Where Medical Properties Trust Stands With Analysts
Medical Properties Trust (NYSE:MPW) has observed the following analyst ratings within the last quarter:
REIT’s Wednesday At The Close: Medical Properties Up, Host Hotels Down
Real estate investment trusts traded generally lower Wednesday with the benchmark Real Estate Select Sector SPDR Fund (NYSEArca: XLRE) giving back 0.63%:
REIT ETF Moves Higher: Also, Medical Properties Trust Up 1.37%, Host Hotels Off By 2.87%
The real estate investment trust benchmark ETF closed strongly today with an advance of 1.99%, its 3rd straight day of gains:
JP Morgan Analyst Lowers Price Targets On These 4 Popular REITs As Recession Fears Rise
JPMorgan Chase & Co. (NYSE: JPM) is slashing price targets on four popular real estate investment trusts (REITs) as recession fears continue to weigh heavily on the market.
Analyst Ratings for Medical Properties Trust
Over the past 3 months, 7 analysts have published their opinion on Medical Properties Trust (NYSE:MPW) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
JP Morgan Downgrades Medical Properties Trust to Neutral, Lowers Price Target to $18
JP Morgan analyst Michael Mueller downgrades Medical Properties Trust (NYSE:MPW) from Overweight to Neutral and lowers the price target from $24 to $18.